亚洲精品嫩草研究院久久

COMPANY PROFILE

公司簡介

Suzhou kunpeng biotechnology co., LTD., founded in February 2013, is a high-tech enterprise located in suzhou. The company takes "providing drugs, technologies and services for human disease control" as its mission and devotes itself to the r&d, production and sales of human drugs.In the field of diabetes treatment drugs, the company has established a product chain including recombinant human insulin, insulin glargine, insulin mendong, lilaru peptide and other drugs by using the unique platform of "protein fixed-point modification technology" and subversive process engineering technology development. At the same time, many new drugs such as new long-acting insulin and glp-1 analogues are also being actively promoted.The company has completed preliminary pre-clinical research in the field of osteoporosis Details>>

獨有的“蛋白定點修飾技術”

Us r&d base


It has established a joint research and development center in cooperation with Texas A&M and signed an agreement on personnel training and technical exchange

Details

Ningbo r&d base


Ningbo research and development center jointly established with the Yangtze river delta research institute of tsinghua university.

Details

Suzhou r&d base


Kunshan small nucleic acid base has built a biomedical entrepreneurship service platform, including analysis and testing platform, pilot plant platform, CRO professional service platform and medical database.

Details

PRODUCT CENTER

產品中心

NEWS CENTER

新聞中心
亚洲精品嫩草研究院久久